CAS-ENVISION

Shenzhen CAS-Envision Medical Technology Co., Ltd.was established in 2018, advocating and practicing the concept of "chip-level medical treatment". It is committed to becoming a platform-based leader in cross-border chip medical innovation.The company is a high-tech start-up company held by SIAT (Shenzhen Institutes of Advanced Technology，Chinese Academy of Sciences).It develops from the technical achievements of "artificial retina" Guangdong innovation team and Shenzhen peacock team which were established by first-class talents introduced from overseas.The preliminary R & D has received a huge funding of nearly 100 million RMB from government and CAS. In 2016, our team won the national championship in the biomedical industry team group of the China Innovation and Entrepreneurship Competition, the highest level of business plan competition in China.In 2020, it won the national runner-up in the IVD start-up group of the China Medical Devices Design & Entrepreneurship Competition.The..

Primary location: Shenzhen